Investors in GERN Stock Encouraged to Participate in Geron Corporation Class Action Lawsuit

Investors who have purchased shares of Geron Corporation (NASDAQ: GERN) may have the opportunity to take part in a class-action lawsuit against the company. The law firm Bronstein, Gewirtz and Grossman, LLC are currently investigating potential claims on behalf of stockholders who have suffered losses as a result of Geron Corporation’s alleged violations of federal securities laws.

The investigation focuses on Geron’s public statements regarding the results of its Phase 2/3 clinical trial of imetelstat for the treatment of myelofibrosis. The lawsuit claims that Geron made misleading statements about the drug’s efficacy and safety, leading to artificially inflated stock prices. When the truth about the trial results emerged, the stock price plummeted, causing financial harm to investors.

In a press release, Geron Corporation announced that it was discontinuing the imetelstat study due to futility in meeting its primary endpoint of overall survival. This news resulted in a significant drop in the company’s stock price. The investigation by Bronstein, Gewirtz and Grossman, LLC seeks to determine if Geron Corporation misled investors about the drug’s potential success in treating myelofibrosis, which may have violated federal securities laws.

Investors who purchased Geron Corporation stock between March 19, 2018, and September 26, 2018, are encouraged to contact Bronstein, Gewirtz and Grossman, LLC to learn more about their rights and potential participation in the class-action lawsuit. The law firm is dedicated to holding companies accountable for their actions and seeking justice for shareholders who have suffered losses due to deceptive practices.

Investors who have been affected by the alleged misconduct of Geron Corporation are urged to contact Bronstein, Gewirtz and Grossman, LLC as soon as possible. The law firm is committed to protecting the interests of investors and holding companies accountable for any violations of securities laws. By participating in the class-action lawsuit, stockholders have the opportunity to seek compensation for their losses and send a message to companies that engage in deceptive practices.

If you are a stockholder of Geron Corporation who purchased shares between March 19, 2018, and September 26, 2018, and have suffered financial losses, it is essential to take action and explore your legal options. Contacting Bronstein, Gewirtz and Grossman, LLC can provide you with the necessary information to protect your rights and potentially seek compensation for any damages you may have incurred as a result of the company’s alleged misconduct.